Selected Grants
Nonhuman Primate Core-Option 6
ResearchInvestigator · Awarded by National Institutes of Health · 2025 - 2032External Quality Assurance Program Oversight Laboratory (EQAPOL)
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2031Transdisciplinary Research in Infectious Diseases to Engage Third-year medical students (TRIDENT) R25
Inst. Training Prgm or CMEInvestigator · Awarded by National Institutes of Health · 2025 - 2030Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2030Multivalent mRNA HIV vaccine using Envelopes from recently circulating viruses.
ResearchCo-Mentor · Awarded by National Institutes of Health · 2025 - 2028HVTN Lab Center: B Cell Supplement
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2023 - 2027Synthetic DNA launched & adjuvanted Immune Focused Env immunogens for HIV
ResearchPrincipal Investigator · Awarded by Wistar Institute of Anatomy and Biology · 2022 - 2027HIV Vaccine Trials Network Laboratory Center
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2027HVTN Laboratory Center: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2027SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Collaboratory of AIDS Researchers for Eradication (CARE)
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2027Infectious Diseases in Africa (IDA) Training Symposium for Next Gen Scientists
ConferencePrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2027Training exchange between THSTI; Pali, India & Duke CFAR Immuno Core to Study Polyfunctionality of anti-HIV1 Antibody responses
ResearchPrincipal Investigator · Awarded by CRDF Global · 2025 - 2026CIVICs Component A Year 7 - Option 6
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2026BNT351-ADxx and FcRN
ResearchPrincipal Investigator · Awarded by BioNTech SE · 2025 - 2026Nonhuman Primate Option 6
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2025The 18th INTERNATIONAL CONFERENCE ON HIV TREATMENT, PATHOGENESIS, AND PREVENTION RESEARCH (INTEREST)
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025CoVPN 5001 A Prospective Study of Acute Immune Responses to SARS-CoV-2 Infection
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2024EQAPOL OPTION 6 (YEAR 7)
ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2024EQAPOL - Years 2017 to 2024 - BASE
ResearchDirector · Awarded by National Institutes of Health · 2017 - 2024Modulation of Antigen Presenting Cell Function by HIV Vaccine induced Antibodies
FellowshipPrincipal Investigator · Awarded by Triangle Community Foundation · 2023 - 2024New Analytic Approaches and Endpoints in Human HIV Vaccine Correlate Studies
ResearchPrincipal Investigator · Awarded by Dartmouth College · 2022 - 202417th INTERNATIONAL CONFERENCE ON HIV TREATMENT, PATHOGENESIS, AND PREVENTION RESEARCH (INTEREST)
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2024HVTN Supplement 2022
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2023CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2023HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2023Targeting the HIV-1 reservoir with a combination of an IDLV-SIVGag therapeutic vaccine and Fc-engineered bnAbs (R01)
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 20232022 International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST)
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2023Infectious Diseases in Africa: Correlates of Protection, Lessons from Vaccines and Natural Infection Studies
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2023HVTN 705 Case Control Janssen
ResearchInvestigator · Awarded by Fred Hutchinson Cancer Center · 2021 - 2022CoVPN 3005: Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older
ResearchCo Investigator · Awarded by Seattle Cancer Care Alliance · 2022 - 2022CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
ResearchCo Investigator · Awarded by Seattle Cancer Care Alliance · 2022 - 2022In vitro characterization of antibody-dependent cellular mediated cytotoxic responses against SARS-CoV-2
ResearchPrincipal Investigator · Awarded by St. Jude Children's Research Hospital · 2021 - 2022Impact of Fc N-glycan structure on HIV-specific antibody functions
ResearchPrincipal Investigator · Awarded by University of Wyoming · 2016 - 2022Early life B cell responses and inflammation following SARS-CoV-2 infection
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2022CARE Focus 1: Latency Biomarker Project
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2018 - 2022CARE Focus 2: Clearance of HIV Antigen-Positive Cells
ResearchInvestigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2022HVTN Laboratory Center: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022Combined Hepatitis B and HIV-1 Envelope Infant Vaccination to Augment T cell Help through Enhanced Linked Recognition
ResearchMentor · Awarded by National Institutes of Health · 2017 - 2022Project 2: Synthetic DNA & Novel Env Vaccine for HIV
ResearchPrincipal Investigator · Awarded by Wistar Institute of Anatomy and Biology · 2015 - 2022Seraworx - EQAPOL ELISPOT SRA
ResearchPrincipal Investigator · Awarded by Seraworx · 2021 - 2021HVTN 705 Pilot
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2021MGD020 IND enabling studies
ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2020 - 2021Primate Contract Expansion for Covid-19
ResearchInvestigator · Awarded by National Institutes of Health · 2020 - 202114th International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST 2020)
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2021Protocol Development Assays
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2019 - 2020HVTN Laboratory Center: HVTN Phase 1
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2020HVTN Laboratory Center: HVTN 118
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2006 - 202013th International Conference on HIV Treatment, Pathogenesis, and Prevention Research (Interest)
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2020Infectious Diseases in Africa: Immune Escape and HIV Vaccines
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2020Exploring Dual-Affinity Re-Targeting Proteins for Cure of Pediatric HIV-1 Infection
ResearchMentor · Awarded by National Institutes of Health · 2016 - 2019Creation of a bnAbnectin
ResearchInvestigator · Awarded by ViiV Healthcare · 2017 - 2019IGM Proposal
ResearchPrincipal Investigator · Awarded by IGM Biosciences, Inc. · 2016 - 20192018 INTEREST Conference
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2019HVTN - A004
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2018HIV Vaccine Trials Network: LC P5 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2018Evaluation of the host immune response and viral molecular phenotype in lung transplant recipients with PTLD
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2017 - 2018CARE Duke-UNC Latency Biomarker Supplement Year 2
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 20182017 INTEREST Conference
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2018Nonhuman Primate Core-Option 6
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2018EQAPOL Option 5
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2017EQAPOL - Option 6 - 2016 to 2017 - ELISPOT
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2017Focus 1: Detection of HIV Antigen-Positive Cells
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2017Invitro Function of DART Molecules (Base)
ResearchPrincipal Investigator · Awarded by MacroGenics, Inc. · 2016 - 2017Infant immune correlates of perinatal mother to child transmission of HIV
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2017Intervening with Latent HIV-1 Infection using Gnidimacrin
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 201710th INTEREST Workshop on HIV
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2017LC: HIV Vaccine Trials Network: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2014 - 2015HIV Vaccine Trials Network: LC P5 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2014 - 2015HIV Envelope-specific functional antibody responses in HIV-exposed, HIV-vaccinated infants
ResearchCollaborator · Awarded by National Institutes of Health · 2012 - 2015HIV-1 Gene Suppression by CD8+ T Cells
ResearchInvestigator · Awarded by National Institutes of Health · 2002 - 2015AIDS International Training and Research Program
ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2014Poly-functional analyses of vaccine-induced T cell responses
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2012Correlates of Vaccine Protection Workshop
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2011International Clinical Trials Unit
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2004 - 2009Infectious Diseases in Africa: Measurement of Immune Responses
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2008Central Laboratory for the HIV Vaccines Trial Network
ResearchResearch Associate · Awarded by National Institutes of Health · 2000 - 2006NCRR FACSAria Cell Sorter
EquipmentCo Investigator · Awarded by National Center for Research Resources · 2004 - 2006Anti-Hiv Ctl And Hiv Suppressive Cd8 Cells
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1990 - 2000Anti-Hiv Ctl And Hiv-Suppresive Cd8+ Cells
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Anti-Hiv Ctl And Hiv Suppresive Cd8+ Cells
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1999Antihiv Ctl And Hiv Suppressive Cd8 Cells
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1990 - 1999External Relationships
- Viiv (GlaxoSmithKline)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.